Fact Sheet

Canadian Consortium on Neurodegeneration in Aging

The vision of the CCNA is to bring together 20 research teams involving over 340 top Canadian researchers in the field of neurodegenerative diseases affecting cognition such as Alzheimer’s in a collaborative and synergistic space. Researchers will work on bold and transformative research ideas to make a difference in the quality of life and the quality of services for those living with dementia and their caregivers.

To promote high impact, the CCNA will include inter-institutional and interdisciplinary collaboration. Researchers will work with key stakeholders such as patients and their families.

What areas of research will the CCNA support?
Research within the CCNA will be organized around three research themes aimed at preventing and mitigating the toll of dementia and related neurodegenerative diseases of aging for individuals and society.

The three themes are:

  • Primary Prevention – aimed at preventing the disease from developing;
  • Secondary Prevention – focused on delaying the clinical manifestations of the already developing disease; and
  • Quality of Life – designed for helping individuals, caregivers and the health system in the context of a clinically developed disease.

Funding

The CCNA is a $31.5M investment from the Government of Canada through the Canadian Institutes of Health Research, and many important partners. The CCNA researchers will also benefit from an additional $24M investment by a subset of the partners in Ontario and Quebec.

  • CCNAfunding partners:

Alberta Prion Research Institute / $150,000
Alzheimer’s Research UK / $300,000
Alzheimer Society of Canada / $4,050,000
Canadian Institutes of Health Research / $21,650,000
Canadian Nurses Foundation / $50,000
Fonds de recherche du Québec – Santé
Pfizer Canada / $5,000,000
Michael Smith Foundation for Health Research / $400,000
New Brunswick Health Research Foundation / $1,080,000
Nova Scotia Health Research Foundation / $125,000
Ontario Brain Institute / $19,000,000
Robin and Barry Picov Foundation / $500,000
Sanofi / $2,500,000
Saskatchewan Health Research Foundation / $500,000
Women’s Brain Health Initiative / $250,000